Sampre Nutritions Board Meeting for Q2 FY27 Results

Sampre Nutritions Limited has intimated BSE Limited about a scheduled meeting of its Board of Directors. The meeting is set to be held on Friday, 06 November 2026.

The primary agenda of the board meeting is to consider and approve the unaudited standalone and consolidated financial results of the Company for the second quarter ended 30 September 2026, for the financial year 2026-27.

The communication was digitally signed by Brahma Gurbani, Managing Director (DIN: 00318180), on behalf of Sampre Nutritions Limited.